Shares of EverQuote (EVER) have gained 18.2% over the past four weeks to close the last trading session at $23.75, but there could still be a solid upside left in the stock if short-term price targets ...
Shares of Dave Inc. (DAVE) have gained 8.2% over the past four weeks to close the last trading session at $223.63, but there could still be a solid upside left in the stock if short-term price targets ...
Shares of Crexendo (CXDO) have gained 8.6% over the past four weeks to close the last trading session at $6.96, but there could still be a solid upside left in the stock if short-term price targets of ...
The Trade Desk TTD stock has seen a sharp 44% slide over the past six months, an uncomfortable drawdown for a company viewed as one of ad tech’s leading players. TTD’s decline stands in sharp contrast ...
Vericel Corporation (VCEL) closed the last trading session at $38.94, gaining 22.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
Palomar (PLMR) closed the last trading session at $121.66, gaining 7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Shares of Skyward Specialty Insurance (SKWD) have gained 8.3% over the past four weeks to close the last trading session at $48.75, but there could still be a solid upside left in the stock if ...
OrthoPediatrics (KIDS) closed the last trading session at $17.01, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
Waystar Holding (WAY) closed the last trading session at $36.22, gaining 1.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
Adma Biologics (ADMA) closed the last trading session at $14.71, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
On Holding (ONON) closed the last trading session at $43.3, gaining 2.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...
Shares of AtriCure (ATRC) have gained 3.5% over the past four weeks to close the last trading session at $37.74, but there could still be a solid upside left in the stock if short-term price targets ...